NCT03549273 2024-02-07
Evaluation Glizigen® and Ocoxin®-Viusid® in High-grade Cervical Intraepithelial Lesions
Catalysis SL
Phase 2 Unknown
Catalysis SL
University Medical Center Groningen
Peking Union Medical College Hospital
Tianjin Medical University Cancer Institute and Hospital
Zhujiang Hospital
THEVAX Genetics Vaccine
Genexine, Inc.
National Cancer Institute (NCI)